Pages
Products

Human FLT4 mRNA

For research use only. Not intended for any clinical use.
Cat.No.
PMRN-0103
Description
The FLT4 mRNA encodes the human Fms related receptor tyrosine kinase 4 (FLT4) protein, a tyrosine kinase receptor for vascular endothelial growth factors C and D. FLT4 is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium.
Alias
CHTD7, FLT-4, FLT41, LMPH1A, LMPHM1, PCL, VEGFR-3, VEGFR3
Features
• mRNA synthesized on error free sequence verified plasmid DNA template
• 100% replacement of UTP with modified nucleotides 5-Methoxy-UTP
• Cap 1 Capping and poly-A tailed incorporated
• Degrades the DNA template after RNA synthesis with DNase
Sequence
MQRGAALCLR LWLCLGLLDG LVSGYSMTPP TLNITEESHV IDTGDSLSIS CRGQHPLEWA WPGAQEAPAT GDKDSEDTGV VRDCEGTDAR PYCKVLLLHE VHANDTGSYV CYYKYIKARI EGTTAASSYV FVRDFEQPFI NKPDTLLVNR KDAMWVPCLV SIPGLNVTLR SQSSVLWPDG QEVVWDDRRG MLVSTPLLHD ALYLQCETTW GDQDFLSNPF LVHITGNELY DIQLLPRKSL ELLVGEKLVL NCTVWAEFNS GVTFDWDYPG KQAERGKWVP ERRSQQTHTE LSSILTIHNV SQHDLGSYVC KANNGIQRFR ESTEVIVHEN PFISVEWLKG PILEATAGDE LVKLPVKLAA YPPPEFQWYK DGKALSGRHS PHALVLKEVT EASTGTYTLA LWNSAAGLRR NISLELVVNV PPQIHEKEAS SPSIYSRHSR QALTCTAYGV PLPLSIQWHW RPWTPCKMFA QRSLRRRQQQ DLMPQCRDWR AVTTQDAVNP IESLDTWTEF VEGKNKTVSK LVIQNANVSA MYKCVVSNKV GQDERLIYFY VTTIPDGFTI ESKPSEELLE GQPVLLSCQA DSYKYEHLRW YRLNLSTLHD AHGNPLLLDC KNVHLFATPL AASLEEVAPG ARHATLSLSI PRVAPEHEGH YVCEVQDRRS HDKHCHKKYL SVQALEAPRL TQNLTDLLVN VSDSLEMQCL VAGAHAPSIV WYKDERLLEE KSGVDLADSN QKLSIQRVRE EDAGRYLCSV CNAKGCVNSS ASVAVEGSED KGSMEIVILV GTGVIAVFFW VLLLLIFCNM RRPAHADIKT GYLSIIMDPG EVPLEEQCEY LSYDASQWEF PRERLHLGRV LGYGAFGKVV EASAFGIHKG SSCDTVAVKM LKEGATASEH RALMSELKIL IHIGNHLNVV NLLGACTKPQ GPLMVIVEFC KYGNLSNFLR AKRDAFSPCA EKSPEQRGRF RAMVELARLD RRRPGSSDRV LFARFSKTEG GARRASPDQE AEDLWLSPLT MEDLVCYSFQ VARGMEFLAS RKCIHRDLAA RNILLSESDV VKICDFGLAR DIYKDPDYVR KGSARLPLKW MAPESIFDKV YTTQSDVWSF GVLLWEIFSL GASPYPGVQI NEEFCQRLRD GTRMRAPELA TPAIRRIMLN CWSGDPKARP AFSELVEILG DLLQGRGLQE EEEVCMAPRS SQSSEEGSFS QVSTMALHIA QADAEDSPPS LQRHSLAARY YNWVSFPGCL ARGAETRGSS RMKTFEEFPM TPTTYKGSVD NQTDSGMVLA SEEFEQIESR HRQESGFSCK GPGQNVAVTR AHPDSQGRRR RPERGARGGQ VFYNSEYGEL SEPSEEDHCS PSARVTFFTD NSY
Species
Homo sapiens (Human)
Storage
Store at or below -70°C. Avoid repeated freeze/thaw cycles. Aliquot if necessary using RNase-free equipment, reagents, pipet tips, tubes, and containers.

Case Study

Publications

Q & A

Customer Reviews

The formation of the lymphatic system requires the coordinated expression of several key regulators: vascular endothelial growth factor C (VEGFC), its receptor FLT4, and the key transcriptional effector PROX1. However, the mechanisms regulating the expression of these signaling pathway components are unclear. Here, researchers combined genetic and molecular biological approaches to identify the transcription factor hematopoietic expression homeobox (HHEX) as an upstream regulator of VEGFC, FLT4, and PROX1 during angiogenic sprouting and lymphangiogenesis in vertebrates. By analyzing zebrafish mutants, researchers found that hhex is an essential factor for vascular sprouting of the posterior cardinal vein, which is required for lymphangiogenesis. In addition, mammalian HHEX was studied by tissue-specific gene deletion in mice and gene knockdown in cultured human endothelial cells, revealing its highly conserved functions during vascular and lymphatic development. These findings indicate that HHEX is essential for the regulation of the VEGFC/FLT4/PROX1 axis, providing insights into the molecular regulation of lymphangiogenesis.

Here, researchers assessed vegfc and flt4 expression at 24 and 32 hpf after fertilization by whole-mount in situ hybridization (Figure 1a-h). At 24 hpf after fertilization, hhex mutants showed reduced expression of flt4, while vegfc expression was slightly increased and ectopically expressed in the PCV (Figure 1a-d). These changes were more pronounced at 32 hpf, as flt4 expression was greatly reduced in hhex mutants, while vegfc expression was significantly increased in the PCV (Figure 1e-h). To test whether the phenotypes observed in hhex mutants were at least partially due to the regulation of the Vegfc/Flt4 signaling pathway, researchers performed a rescue experiment by injecting messenger RNA (mRNA) encoding full-length human FLT4. Confocal imaging of the main trunk vessels of hhex mutant larvae and quantitative analysis of vISV and thoracic duct (TD) extension showed that vISV and lymphatic vessel formation were partially restored after injection of FLT4 mRNA (Figure 1i-l), indicating that the Vegfc/Flt4 signaling pathway functions downstream of Hhex. Taken together, these results indicate that Hhex is a key regulator of flt4 and vegfc expression in PCVs during angiogenic sprouting.

Figure 1. The Vegfc/Flt4 pathway is affected in zebrafish hhex mutants. (Gauvrit S, et al., 2018)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction

CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER
Quick Inquiry

Inquiry